(NYSE:RFL),(NYSE MKT:RFL-WT), NEWARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) — Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) announced today that its subsidiary Cyclo Therapeutics has had two abstracts selected for presentation from its programs evaluating Trappsol(R) Cyclo(TM) for the treatment of Niemann-Pick Disease Type C1 at the upcoming 15th International Congress of Inborn Errors […]

CHICAGO, Aug. 27, 2025 (GLOBE NEWSWIRE) — As the nation prepares to honor Labor Day, the Financial Health Network is unveiling a groundbreaking report that provides employers with unprecedented clarity on how to support employee financial health. Essential Benefits: A New North Star for Wage and Benefit Design is the first study of its kind

(NASDAQ:DSGN), CARLSBAD, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2025 Cantor Global Healthcare Conference on Thursday, September 4, 2025, at 10:55 a.m. ET in New York. A

(NasdaqGM:SEPN), SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) — Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate in the following upcoming investor conferences in September: Cantor Global Healthcare Conference 2025 Presentation on Wednesday, September 3, 2025,

(NasdaqGM:RAPT), SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in September:

(NASDAQ:SLNO), REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in September: Cantor Global Healthcare ConferencePresentation Date: Wednesday, September 3, 2025 at 1:00 PM ETPresentation Format:

(NASDAQ:MDXG), MARIETTA, Ga., Aug. 27, 2025 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Cantor Global Healthcare Conference | New York, NYWednesday, September 3, 2025Fireside Chat (1:35 PM ET): Click here to access Lake Street BIG9

SEATTLE, WA, Aug. 27, 2025 (GLOBE NEWSWIRE) — As AI-moderated interviews reshape qualitative research, many companies frame it as a choice between automation or human connection. Discuss, the only global market insights platform proven to deliver both, today announced new features that cement the hybrid model of AI-led and human-led research as the industry's new

NEW YORK, NY, Aug. 27, 2025 (GLOBE NEWSWIRE) — T-RIZE Group, a global fintech firm offering institutional-grade tokenization infrastructure, is launching Vision 60 by Ste-Rose, a $24.2 million, 60-unit energy-efficient residential development in Laval, Quebec. This project is part of a 500+ unit new construction deal with T-RIZE Group, valued at $200 million. Tokenized by

San Mateo, CA, Aug. 27, 2025 (GLOBE NEWSWIRE) — BriteCore, a leading provider of cloud-native core insurance platforms for P&C insurers, announced today it is hosting a webinar at 2:00 p.m. EST on September 18, 2025 to share insights, best practices, and new approaches for reducing payment processing expenses for insurers. The webinar titled, How